BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu CE, Yeh CN. Cutting Edge Research for Exploration of Biomolecules for Gemcitabine-Based Chemo-Resistant Advanced Bile Duct Cancer: From Basic Study to Clinical Trial. Biomolecules 2021;11:1626. [PMID: 34827625 DOI: 10.3390/biom11111626] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Chen Q, Cui S, Huang J, Wang J, Wang D, Wang H, Lyu S, Lang R. Venous thromboembolism in patients undergoing distal cholangiocarcinoma surgery: Prevalence, risk factors, and outcome. Asian J Surg 2023:S1015-9584(23)00179-3. [PMID: 36797089 DOI: 10.1016/j.asjsur.2023.02.015] [Reference Citation Analysis]
2 Cheng C, Chen C, Wu C. Precision Medicine in Cholangiocarcinoma: Past, Present, and Future. Life 2022;12:829. [DOI: 10.3390/life12060829] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]